A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the bioequivalence of alendronate in combination with vitamin D
(cholecalciferol) compared to alendronate alone and the bioequivalence of vitamin D in
combination with alendronate compared to vitamin D alone.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Alendronate Cholecalciferol Ergocalciferols Vitamin D Vitamins